Skip navigation
Skip navigation

A phase 1/11 study of pemetrexed and vinorelbine in patients with non-small cell lung cancer

Clarke, Stephen J; Boyer, Michael J; Millward, Michael; Underhill, Craig; Moylan, Eugene; Yip, Desmond; White, Shane; Childs, Annabel; Beale, Phillip; Latz, Jane; Suri, Ajit; Iglesias, Jose


Purpose: Pemetrexed and vinorelbine are active antineoplastic agents in non-small cell lung cancer (NSCLC). Phase I objectives include maximum tolerated dose (MTD) and recommended phase II dose determination, and pharmacokinetics of the pemetrexed-vinorelbine doublet in locally advanced or metastatic solid tumor patients (pts). Phase II objectives include tumor response evaluation, efficacy, and toxicity for first-line treatment of advanced NSCLC. Experimental design: Phase I pts received...[Show more]

CollectionsANU Research Publications
Date published: 2005
Type: Journal article
Source: Lung Cancer
DOI: 10.1016/j.lungcan.2005.04.003


File Description SizeFormat Image
01_Clarke_A_phase_1/11_study_of_2005.pdf176.37 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  23 August 2018/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator